113 related articles for article (PubMed ID: 8968342)
1. In vivo 125I-erythropoietin pharmacokinetics are unchanged after anesthesia, nephrectomy and hepatectomy in sheep.
Widness JA; Veng-Pedersen P; Schmidt RL; Lowe LS; Kisthard JA; Peters C
J Pharmacol Exp Ther; 1996 Dec; 279(3):1205-10. PubMed ID: 8968342
[TBL] [Abstract][Full Text] [Related]
2. Changes in erythropoietin pharmacokinetics following busulfan-induced bone marrow ablation in sheep: evidence for bone marrow as a major erythropoietin elimination pathway.
Chapel S; Veng-Pedersen P; Hohl RJ; Schmidt RL; McGuire EM; Widness JA
J Pharmacol Exp Ther; 2001 Aug; 298(2):820-4. PubMed ID: 11454947
[TBL] [Abstract][Full Text] [Related]
3. Comparative pharmacokinetics and distribution of human urinary erythropoietin and recombinant human erythropoietin in rats.
Kinoshita H; Ohishi N; Kato M; Tokura S; Okazaki A
Arzneimittelforschung; 1991 Sep; 41(9):1004-7. PubMed ID: 1796912
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and distribution of recombinant human erythropoietin in rats with renal dysfunction.
Kinoshita H; Ohishi N; Tokura S; Okazaki A
Arzneimittelforschung; 1992 May; 42(5):682-6. PubMed ID: 1530684
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and distribution of recombinant erythropoietin in rats.
Kinoshita H; Ohishi N; Kato M; Tokura S; Okazaki A
Arzneimittelforschung; 1992 Feb; 42(2):174-8. PubMed ID: 1610430
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of recombinant human erythropoietin in rabbits and 3/4 nephrectomized rats.
Yoon WH; Park SJ; Kim IC; Lee MG
Res Commun Mol Pathol Pharmacol; 1997 May; 96(2):227-40. PubMed ID: 9226757
[TBL] [Abstract][Full Text] [Related]
7. Distribution of recombinant human erythropoietin following multiple intravenous administration and effects of age on the distribution in rats.
Kinoshita H; Ohishi N; Kato M; Tokura S; Okazaki A
Arzneimittelforschung; 1992 Apr; 42(4):579-84. PubMed ID: 1642686
[TBL] [Abstract][Full Text] [Related]
8. Developmental differences in erythropoietin pharmacokinetics: increased clearance and distribution in fetal and neonatal sheep.
Widness JA; Veng-Pedersen P; Modi NB; Schmidt RL; Chestnut DH
J Pharmacol Exp Ther; 1992 Jun; 261(3):977-84. PubMed ID: 1602403
[TBL] [Abstract][Full Text] [Related]
9. A sensitive and specific erythropoietin immunoprecipitation assay: application to pharmacokinetic studies.
Widness JA; Schmidt RL; Veng-Pedersen P; Modi NB; Sawyer ST
J Lab Clin Med; 1992 Mar; 119(3):285-94. PubMed ID: 1311741
[TBL] [Abstract][Full Text] [Related]
10. Immunological response to repeated administration of recombinant human erythropoietin in rats: biphasic effect on its pharmacokinetics.
Kato M; Miura K; Kamiyama H; Okazaki A; Kumaki K; Kato Y; Sugiyama Y
Drug Metab Dispos; 1997 Sep; 25(9):1039-44. PubMed ID: 9311618
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of erythropoietin in intact and anephric dogs.
Fu JS; Lertora JJ; Brookins J; Rice JC; Fisher JW
J Lab Clin Med; 1988 Jun; 111(6):669-76. PubMed ID: 3373111
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of erythropoietin in genetically anemic mice.
Kato M; Miura K; Kamiyama H; Okazaki A; Kumaki K; Kato Y; Sugiyama Y
Drug Metab Dispos; 1998 Feb; 26(2):126-31. PubMed ID: 9456298
[TBL] [Abstract][Full Text] [Related]
13. Role of antennary structure of N-linked sugar chains in renal handling of recombinant human erythropoietin.
Misaizu T; Matsuki S; Strickland TW; Takeuchi M; Kobata A; Takasaki S
Blood; 1995 Dec; 86(11):4097-104. PubMed ID: 7492766
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and haematological parameters of recombinant human erythropoietin after subcutaneous administrations in horses.
Souillard A; Audran M; Bressolle F; Jaussaud P; Gareau R
Biopharm Drug Dispos; 1996 Dec; 17(9):805-15. PubMed ID: 8968532
[TBL] [Abstract][Full Text] [Related]
15. Preparation of iodine labeled recombinant human erythropoietin.
Kinoshita H; Ohishi N; Okazaki A
Arzneimittelforschung; 1991 May; 41(5):568-70. PubMed ID: 1898429
[TBL] [Abstract][Full Text] [Related]
16. Liver as the primary site of erythropoietin formation in the fetus.
Zanjani ED; Poster J; Burlington H; Mann LI; Wasserman LR
J Lab Clin Med; 1977 Mar; 89(3):640-4. PubMed ID: 839121
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic/pharmacodynamic analysis of paradoxal regulation of erythropoietin production in acute anemia.
Al-Huniti NH; Widness JA; Schmidt RL; Veng-Pedersen P
J Pharmacol Exp Ther; 2004 Jul; 310(1):202-8. PubMed ID: 14988424
[TBL] [Abstract][Full Text] [Related]
18. Mechanism for the nonlinear pharmacokinetics of erythropoietin in rats.
Kato M; Kamiyama H; Okazaki A; Kumaki K; Kato Y; Sugiyama Y
J Pharmacol Exp Ther; 1997 Nov; 283(2):520-7. PubMed ID: 9353365
[TBL] [Abstract][Full Text] [Related]
19. The pharmacokinetics of recombinant human erythropoietin in Balkan endemic nephropathy patients.
Ležaić V; Petković N; Marić I; Miljković B; Vučićević K; Simić-Ogrizović S; Pejovic V; Djukanović L
Nefrologia; 2013; 33(4):478-85. PubMed ID: 23897179
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic tracer kinetics analysis of changes in erythropoietin receptor population in phlebotomy-induced anemia and bone marrow ablation.
Veng-Pedersen P; Chapel S; Al-Huniti NH; Schmidt RL; Sedars EM; Hohl RJ; Widness JA
Biopharm Drug Dispos; 2004 May; 25(4):149-56. PubMed ID: 15108217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
